Mitochondria-Targeted Delivery of Camptothecin Based on HPMA Copolymer for Metastasis Suppression
Poor anti-metastasis effects and side-effects remain a challenge for the clinical application of camptothecin (CPT). Mitochondria can be a promising target for the treatment of metastatic tumors due to their vital roles in providing energy supply, upregulating pro-metastatic factors, and controlling...
Saved in:
Main Authors: | Xiaoli Yi (Author), Yue Yan (Author), Xinran Shen (Author), Lian Li (Author), Yuan Huang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo
by: Martin Studenovský, et al.
Published: (2022) -
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
by: Marina R. Tavares, et al.
Published: (2021) -
Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria
by: Aysegul Ekmekcioglu, et al.
Published: (2024) -
Mitochondria: a new intervention target for tumor invasion and metastasis
by: Quanling Zhou, et al.
Published: (2024) -
Mitochondria-targeted drug delivery
Published: (2022)